ArticlePatient preference and adherence2026

What Matters Most to Patients with NSCLC When Choosing Anticancer Treatments in China? A Best-Worst Scaling Study.

Jingyi Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.